Schreiner MediPharm’s multi-functional booklet-label combines several digital security features with an integrated first-opening seal.
Schreiner MediPharm’s new booklet-label solution combines several digital security features with an integrated first-opening seal. The bottom layer contains a tab serving as a closure seal for tampering protection. When the seal is opened, a void effect emerges as an irreversible first-opening indication. Applied to a medicine carton, the Booklet-Label allows the user to view the medication's product information without opening the pack and destroying the tamper protection.
The label is also equipped with three digital security features. The BitSecure copy detection technology is based on a high-resolution, cloud-like random pattern. The BitSecure pattern requires a minimal size of a few square millimeters and can be integrated into the pharmaceutical manufacturer’s existing brand appearance. The KeySecure tracing system is based on an encrypted 15-digit alphanumerical code, which makes it possible to identify and authenticate every product item marked using a smartphone or the Internet. The code can be printed in human-readable form or as a 2D code. A label-integrated NFC Chip enables digital authentication using a smartphone. The NFC chip blends in with the label design and allows for contactless product identification within a few centimeters.
Source: Schreiner MediPharm
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.